Enhancing Radiation Safety for Nuclear Medicine Radiographers: the Impact of Introducing the Automat-ed Radiopharmaceutical Preparation and Administration System
NCT ID: NCT06371703
Last Updated: 2024-10-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
100 participants
OBSERVATIONAL
2024-10-31
2024-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Preparation of Radiopharmaceuticals by Automaton: Operators Dosimetry
NCT03974256
The RAD-HOME Project: a Pilot Study of Domiciliary Teleradiology
NCT01098916
320-slice Coronary Computed Tomography (CT) Angiography
NCT00721851
Interest of the SPECT-CT Scan SUVspect in the New Generation of Gamma-cameras With Semiconductor
NCT03414021
Optimized Camera-based Patient Positioning in CT
NCT05135208
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CROSSOVER
CROSS_SECTIONAL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
automated system in reducing radiation exposure
evaluate the effectiveness of the automated system in reducing radiation exposure for radiographers involved in PET/CT procedures.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2\) Nuclear medicine healthcare professionals with experience in radiopharmaceutical administration.
3\) Ability to provide written informed consent.
Exclusion Criteria
2\) Nuclear medicine healthcare professionals without experience in radiopharmaceutical administration.
3\) Inability to provide written informed consent.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
IRCCS San Raffaele
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Chiti Arturo
PI
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Arturo Chiti
Role: STUDY_DIRECTOR
IRCCS Ospedale San Raffaele
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Irccs San Raffaele
Milan, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PETCT_INTEGO
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.